BICO Acquires Assets and Operations of HUREL Corp. for ~$2.5M

BICO has acquired the assets and operations of HUREL Corp., a US-based provider of 2D liver co-culture models and assay services, for approximately USD 2.5 million. The HUREL portfolio and team will be integrated into BICO subsidiary Visikol to expand the group's liver in vitro model and assay offerings for pharma, biotech and academic customers.